1. Townsend DW, Carney JPJ, Yap JT, Hall NC. PET/CT today and tomorrow. J Nucl Med 2004;45:4s–14s
2. Hasegawa BH, Zaidi H. Dual-modality imaging: more than the some of its components. In: Zaidi H, editor. Quantitative analysis in nuclear medicine imaging. Berlin Heidelberg New York: Springer; 2005; p. 35–81
3. Zaidi H, Hasegawa BH. Determination of the attenuation map in emission tomography. J Nucl Med 2003;44:291–315
4. Antoch G, Freudenberg LS, Stattaus J, Jentzen W, Mueller SP, Debatin JF, et al. Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials. AJR Am J Roentgenol 2002;179:1555–1560
5. Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF. To enhance or not enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med 2004;45:56S–95S